Insider Trading activities of Exelixis Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exelixis Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exelixis Inc since year 2005. Table 2 shows the detailed insider transactions of Exelixis Inc since 2005. The reporting company's ticker symbol is EXEL. The reporting company's CIK number is 939767.
The total value of stock buying since 2005 is $3,904,031.
The total value of stock sales since 2005 is $74,410,256.
The total value of stock option exercises since 2005 is $21,145,608.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Exelixis Inc (EXEL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 897,942 $23,919,083 527,302 $1,918,872
2017-05 0 $0 598,347 $13,258,833 591,860 $2,024,351
2017-04 0 $0 10,000 $213,000 20,090 $205,291
2017-03 0 $0 600,578 $13,508,762 616,257 $4,602,550
2017-02 0 $0 70,000 $1,305,500 70,000 $459,900
2017-01 0 $0 70,000 $1,046,500 70,000 $363,300
2016-12 0 $0 329,726 $5,741,547 485,332 $4,131,934
2016-11 0 $0 292,000 $4,250,500 292,000 $2,364,679
2016-08 0 $0 173,493 $1,905,799 175,000 $1,702,749
2016-06 0 $0 0 $0 200,000 $340,000
2016-05 60,000 $297,920 0 $0 0 $0
2015-12 100,000 $488,549 0 $0 0 $0
2015-11 0 $0 0 $0 5,208 $0
2015-10 0 $0 352,425 $2,055,775 352,425 $1,984,151
2014-11 0 $0 0 $0 11,646 $0
2014-09 20,000 $34,200 0 $0 0 $0
2014-02 0 $0 0 $0 12,268 $0
2013-11 0 $0 0 $0 17,473 $0
2013-08 10,000 $51,400 0 $0 12,266 $0
2013-05 0 $0 0 $0 12,264 $0
2013-02 0 $0 0 $0 12,267 $0
2012-12 35,000 $156,795 0 $0 0 $0
2012-11 0 $0 0 $0 17,474 $0
2012-08 0 $0 0 $0 12,266 $0
2012-06 0 $0 7,000 $35,917 0 $0
2012-05 0 $0 0 $0 12,264 $0
2012-02 0 $0 0 $0 12,267 $0
2011-11 0 $0 0 $0 12,265 $0
2011-08 0 $0 0 $0 14,844 $0
2011-05 0 $0 0 $0 19,842 $0
2011-02 0 $0 0 $0 74,376 $0
2010-12 0 $0 108,539 $835,207 104,427 $570,120
2010-09 36,200 $130,403 0 $0 0 $0
2010-08 446,500 $1,359,351 0 $0 0 $0
2009-12 0 $0 12,500 $98,625 12,500 $63,000
2009-11 0 $0 2,529 $15,657 0 $0
2009-06 0 $0 18,806 $94,165 0 $0
2008-10 392,500 $1,276,125 0 $0 0 $0
2008-03 0 $0 2,213 $11,014 0 $0
2008-02 0 $0 10,000 $65,801 0 $0
2008-01 0 $0 15,000 $111,424 0 $0
2007-12 0 $0 12,500 $111,060 0 $0
2007-11 0 $0 10,000 $93,659 0 $0
2007-10 0 $0 8,125 $97,987 0 $0
2007-07 0 $0 18,125 $212,640 0 $0
2007-06 0 $0 18,125 $211,961 0 $0
2007-05 0 $0 12,500 $140,573 0 $0
2007-04 0 $0 10,000 $107,738 0 $0
2007-03 0 $0 7,500 $72,427 0 $0
2007-02 0 $0 12,500 $132,011 0 $0
2007-01 0 $0 10,000 $96,134 0 $0
2006-12 0 $0 10,000 $91,002 0 $0
2006-11 0 $0 12,500 $108,246 0 $0
2006-10 0 $0 10,000 $96,404 0 $0
2006-09 0 $0 10,000 $91,296 0 $0
2006-08 0 $0 12,500 $107,187 0 $0
2006-07 0 $0 15,000 $139,701 0 $0
2006-06 0 $0 7,500 $75,509 0 $0
2006-05 0 $0 23,124 $244,909 15,624 $99,711
2006-04 0 $0 50,000 $559,354 40,000 $252,000
2006-03 0 $0 32,500 $366,599 10,000 $63,000
2006-02 0 $0 12,500 $127,875 0 $0
2006-01 0 $0 10,000 $106,898 0 $0
2005-12 0 $0 10,000 $90,154 0 $0
2005-11 0 $0 12,500 $104,842 0 $0
2005-10 0 $0 10,000 $74,889 0 $0
2005-09 0 $0 280,458 $2,187,008 0 $0
2005-04 0 $0 7,500 $55,527 0 $0
2005-03 0 $0 5,000 $33,557 0 $0
2004-03 2,800 $24,951 0 $0 0 $0
2004-02 7,200 $60,437 0 $0 0 $0
2002-04 2,000 $23,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Exelixis Inc insiders (EXEL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-28 Hessekiel Jeffrey (EVP and General Counsel) Sale 25,000 24.32 608,000
2017-09-28 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 25,000 1.90 47,500
2017-09-28 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,334 23.74 791,349
2017-09-28 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,334 9.91 330,339
2017-09-27 Hessekiel Jeffrey (EVP and General Counsel) Sale 2,302 23.90 55,017
2017-09-27 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 2,302 1.90 4,373
2017-09-27 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,333 23.94 797,992
2017-09-27 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,333 9.91 330,330
2017-09-26 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 33,333 23.68 789,325
2017-09-26 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 33,333 9.91 330,330
2017-09-22 Papadopoulos Stelios Sale 10,000 25.40 254,000
2017-09-19 Papadopoulos Stelios Sale 127,790 27.63 3,530,837
2017-09-18 Papadopoulos Stelios Sale 72,210 27.76 2,004,549
2017-09-14 Haley Patrick J. (Sr. Vice President, Commercial) Sale 60,640 27.21 1,650,014
2017-09-14 Morrissey Michael (President and CEO) Sale 100,000 27.08 2,708,000
2017-09-14 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-09-13 Willsey Lance Sale 50,000 26.97 1,348,500
2017-09-13 Morrissey Michael (President and CEO) Sale 100,000 27.04 2,704,000
2017-09-13 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-09-12 Senner Christopher J. (EVP and CFO) Sale 100,000 26.79 2,679,000
2017-09-12 Senner Christopher J. (EVP and CFO) Option Ex 100,000 3.66 366,000
2017-09-12 Willsey Lance Sale 50,000 26.79 1,339,500
2017-09-12 Morrissey Michael (President and CEO) Sale 100,000 26.59 2,659,000
2017-09-12 Morrissey Michael (President and CEO) Option Ex 100,000 1.70 170,000
2017-05-30 Haley Patrick J. (Sr. Vice President, Commercial) Sale 5,000 18.46 92,300
2017-05-15 Feldbaum Carl B Sale 32,988 21.58 711,881
2017-05-15 Feldbaum Carl B Option Ex 19,000 9.81 186,485
2017-05-15 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 12,501 5.04 63,005
2017-05-10 Morrissey Michael (President and CEO) Sale 100,000 22.07 2,207,000
2017-05-10 Morrissey Michael (President and CEO) Option Ex 100,000 1.80 180,000
2017-05-09 Morrissey Michael (President and CEO) Sale 100,000 21.68 2,168,500
2017-05-09 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-08 Morrissey Michael (President and CEO) Sale 11,300 21.81 246,453
2017-05-08 Morrissey Michael (President and CEO) Option Ex 11,300 1.90 21,470
2017-05-05 Morrissey Michael (President and CEO) Sale 100,000 21.76 2,176,000
2017-05-05 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-04 Morrissey Michael (President and CEO) Sale 59,149 22.17 1,311,333
2017-05-04 Morrissey Michael (President and CEO) Option Ex 59,149 1.90 112,383
2017-05-03 Morrissey Michael (President and CEO) Sale 100,000 22.64 2,263,500
2017-05-03 Morrissey Michael (President and CEO) Option Ex 100,000 1.90 190,000
2017-05-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 89,910 23.16 2,081,866
2017-05-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 89,910 9.91 891,008
2017-04-17 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 10,090 9.91 99,991
2017-04-03 Marchesi Vincent T Sale 10,000 21.30 213,000
2017-04-03 Marchesi Vincent T Option Ex 10,000 10.53 105,300
2017-03-31 Wyszomierski Jack L Sale 5,150 21.57 111,085
2017-03-31 Wyszomierski Jack L Option Ex 10,000 10.53 105,300
2017-03-27 Hessekiel Jeffrey (EVP and General Counsel) Sale 6,884 21.02 144,701
2017-03-27 Cohen Charles Option Ex 10,000 10.53 105,300
2017-03-22 Hessekiel Jeffrey (EVP and General Counsel) Sale 23,787 20.54 488,584
2017-03-22 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 55,000 1.70 93,500
2017-03-20 Feldbaum Carl B Sale 10,000 21.77 217,700
2017-03-20 Feldbaum Carl B Option Ex 10,000 10.53 105,300
2017-03-20 Papadopoulos Stelios Sale 10,000 21.66 216,600
2017-03-20 Papadopoulos Stelios Option Ex 10,000 10.53 105,300
2017-03-15 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 50,007 22.53 1,126,657
2017-03-15 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 50,007 5.80 290,040
2017-03-15 Willsey Lance Sale 10,000 22.86 228,600
2017-03-15 Willsey Lance Option Ex 10,000 10.53 105,300
2017-03-13 Cohen Charles Sale 10,000 21.82 218,200
2017-03-10 Marchesi Vincent T Sale 40,000 21.98 879,200
2017-03-10 Marchesi Vincent T Option Ex 40,000 3.13 125,200
2017-03-06 Morrissey Michael (President and CEO) Sale 100,000 22.61 2,261,000
2017-03-06 Morrissey Michael (President and CEO) Option Ex 100,000 9.91 991,000
2017-03-03 Haley Patrick J. (Sr. Vice President, Commercial) Sale 2,500 23.04 57,600
2017-03-03 Senner Christopher J. (EVP and CFO) Sale 11,000 22.80 250,800
2017-03-03 Hessekiel Jeffrey (EVP and General Counsel) Sale 100,000 23.08 2,308,300
2017-03-03 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 100,000 7.27 727,000
2017-03-03 Morrissey Michael (President and CEO) Sale 100,000 22.83 2,283,000
2017-03-03 Morrissey Michael (President and CEO) Option Ex 100,000 9.91 991,000
2017-03-02 Poste George Sale 67,400 22.58 1,521,892
2017-03-02 Poste George Option Ex 67,400 6.45 434,595
2017-03-01 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 45,000 22.19 998,550
2017-03-01 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 45,000 7.34 330,525
2017-03-01 Poste George Sale 8,850 22.18 196,293
2017-03-01 Poste George Option Ex 8,850 10.53 93,190
2017-02-01 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 70,000 18.65 1,305,500
2017-02-01 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 70,000 6.57 459,900
2017-01-03 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 70,000 14.95 1,046,500
2017-01-03 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 70,000 5.19 363,300
2016-12-16 Feldbaum Carl B Sale 25,000 17.03 425,750
2016-12-16 Feldbaum Carl B Option Ex 25,000 10.41 260,250
2016-12-09 Garber Alan M Sale 7,832 16.90 132,360
2016-12-09 Garber Alan M Option Ex 10,000 10.53 105,300
2016-12-07 Scangos George A Sale 176 17.90 3,150
2016-12-07 Scangos George A Option Ex 356 8.99 3,200
2016-12-05 Scangos George A Sale 204,718 17.81 3,646,027
2016-12-05 Scangos George A Option Ex 357,976 8.99 3,218,204
2016-12-01 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 70,000 16.66 1,166,200
2016-12-01 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 70,000 4.96 347,200
2016-12-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,000 16.73 368,060
2016-12-01 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,000 8.99 197,780
2016-11-09 Lamb Peter (EVP, Scientific Strategy & CSO) Sale 70,000 13.15 920,500
2016-11-09 Lamb Peter (EVP, Scientific Strategy & CSO) Option Ex 70,000 5.27 368,899
2016-11-09 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 22,000 15.00 330,000
2016-11-09 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 22,000 8.99 197,780
2016-11-09 Morrissey Michael (President and CEO) Sale 200,000 15.00 3,000,000
2016-11-09 Morrissey Michael (President and CEO) Option Ex 200,000 8.99 1,798,000
2016-08-31 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 131,155 10.98 1,440,081
2016-08-31 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 132,662 9.73 1,290,801
2016-08-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Sale 42,338 11.00 465,718
2016-08-04 Schwab Gisela (Pres Prod Dev & Med Aff & CMO) Option Ex 42,338 9.73 411,948
2016-06-01 Hessekiel Jeffrey (EVP and General Counsel) Option Ex 200,000 1.70 340,000
2016-05-11 Willsey Lance Buy 20,000 4.95 99,000
2016-05-09 Willsey Lance Buy 40,000 4.97 198,920
2015-12-11 Willsey Lance Buy 50,000 4.78 239,000
2015-12-10 Willsey Lance Buy 50,000 4.99 249,549
2015-11-16 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 2,083 .00 0
2015-11-16 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 3,125 .00 0
2015-10-16 Lamb Peter (EVP, Discovery Research & CSO) Sale 51,549 5.80 298,984
2015-10-16 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 51,549 5.63 290,220
2015-10-13 Lamb Peter (EVP, Discovery Research & CSO) Sale 600 5.80 3,480
2015-10-13 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 600 5.63 3,378
2015-10-12 Lamb Peter (EVP, Discovery Research & CSO) Sale 300,276 5.84 1,753,311
2015-10-12 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 300,276 5.63 1,690,553
2014-11-15 Burke Deborah (SVP & Chief Financial Officer) Option Ex 6,438 .00 0
2014-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 2,083 .00 0
2014-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 3,125 .00 0
2014-09-17 Marchesi Vincent T (Director) Buy 20,000 1.71 34,200
2014-02-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,126 .00 0
2014-02-15 Karbe Frank (EVP and CFO) Option Ex 1,954 .00 0
2014-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2014-02-15 Simonton Pamela A (EVP, Exelixis) Option Ex 1,875 .00 0
2014-02-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-11-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 5,208 .00 0
2013-11-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-11-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 5,312 .00 0
2013-11-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-11-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-08-29 Willsey Lance (Director) Buy 10,000 5.14 51,400
2013-08-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,125 .00 0
2013-08-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-08-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2013-08-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-08-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-05-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,124 .00 0
2013-05-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-05-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,187 .00 0
2013-05-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-05-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2013-02-15 Lamb Peter (EVP, Discovery Research & CSO) Option Ex 3,126 .00 0
2013-02-15 Karbe Frank (EVP and CFO) Option Ex 1,953 .00 0
2013-02-15 Schwab Gisela (EVP and Chief Medical Officer) Option Ex 2,188 .00 0
2013-02-15 Simonton Pamela A (EVP and General Counsel) Option Ex 1,875 .00 0
2013-02-15 Morrissey Michael (President and CEO) Option Ex 3,125 .00 0
2012-12-20 Marchesi Vincent T (Director) Buy 4,000 4.68 18,720
2012-12-19 Marchesi Vincent T (Director) Buy 1,500 4.67 7,005
2012-12-18 Marchesi Vincent T (Director) Buy 1,500 4.82 7,230
2012-12-17 Marchesi Vincent T (Director) Buy 3,000 4.70 14,091
2012-12-10 Schwab Gisela (EVP and Chief Medical Officer) Buy 25,000 4.39 109,749
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of EXEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exelixis Inc (symbol EXEL, CIK number 939767) see the Securities and Exchange Commission (SEC) website.